Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucagon-like Peptide-2.

Jennifer L Estall1, Daniel J Drucker

  • 1Department of Laboratory Medicine and Pathobiology, The Banting and Best Diabetes Center, Toronto General Hospital, University of Toronto, Ontario, Canada, M5G 2C4.

Annual Review of Nutrition
|April 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut-Derived GLP-1 Released by Rare Sugar d-Allulose Cooperates With Insulin to Activate Left-Sided Vagal Afferents and Enhance Insulin Sensitivity.

Diabetes·2026
Same author

The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors.

Cell metabolism·2026
Same author

Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.

JCI insight·2026
Same author

Glucagon promotes net hepatic glycogen repletion following meal ingestion.

JCI insight·2026
Same author

Ectopic, hepatic GLP-1R agonism enhances the weight loss efficacy of GLP-1 analogues.

Molecular metabolism·2026
Same author

Glucagon-like peptide-1 medicines and cancer.

Nature cancer·2026
Same journal

Mechanisms of NAD+ Homeostasis in Aging and Disease.

Annual review of nutrition·2026
Same journal

Metabolite Damage and Repair in Health and Disease.

Annual review of nutrition·2026
Same journal

From Food to Function: Cross-Kingdom Transfer and Regulatory Potential of Dietary microRNAs Highlighted by Breast Milk.

Annual review of nutrition·2026
Same journal

The Influence of Diet on Cancer Progression and Treatment.

Annual review of nutrition·2026
Same journal

The Potential Physiologic Mechanisms by Which Early-Life Nutrition May Influence Type 2 Diabetes Pathophysiology in Humans.

Annual review of nutrition·2026
Same journal

The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms.

Annual review of nutrition·2026
See all related articles

Glucagon-like peptide-2 (GLP-2) is a key gut hormone regulating energy and metabolism. Research explores its therapeutic potential for gastrointestinal diseases by examining its mechanisms and actions in the gut.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Metabolism

Background:

  • Gastrointestinal peptide hormones regulate energy homeostasis and metabolism.
  • Glucagon-like peptide-2 (GLP-2) is an intestinotrophic peptide released post-ingestion.
  • GLP-2 is vital for adaptive regulation of bowel mass and mucosal integrity.

Purpose of the Study:

  • To provide an overview of GLP-2 biology.
  • To highlight recent findings on GLP-2's role in the GI tract.
  • To explore GLP-2's therapeutic potential for GI diseases.

Main Methods:

  • Review of current physiological research on GLP-2.
  • Analysis of studies on GLP-2's mechanisms of action.
  • Synthesis of findings on GLP-2 in normal and diseased GI states.

Related Experiment Videos

Main Results:

  • GLP-2 exhibits potent growth-promoting and cytoprotective effects in the GI tract.
  • Ongoing research focuses on elucidating GLP-2's physiological mechanisms.
  • Factors regulating GLP-2's biological actions are under investigation.

Conclusions:

  • GLP-2 holds therapeutic promise for GI conditions characterized by malabsorption, inflammation, or mucosal damage.
  • Understanding GLP-2's intricate biological mechanisms is crucial for its clinical application.
  • Further research is essential to fully harness GLP-2's potential in treating GI disorders.